Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Oral Proteins and Peptides market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.0% during the forecast period.
This report presents the market size and development trends by detailing the Oral Proteins and Peptides market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Oral Proteins and Peptides market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Oral Proteins and Peptides industry and will help you to build a panoramic view of the industrial development.
Oral Proteins and Peptides Market, By Type:
Linaclotide
Plecanatide
Calcitonin
Insulin
Octreotide
Oral Proteins and Peptides Market, By Application:
Gastric & Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders
Some of the leading players are as follows:
Generex Biotechnology
Synthetic Biologics
Synergy Pharmaceuticals
Biocon
Sanofi
Novo Nordisk
Novartis
Allergan
Hoffmann-La Roche
AstraZeneca
Tarsa Therapeutics
Hovione
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Oral Proteins and Peptides Market: Technology Type Analysis
-
4.1 Oral Proteins and Peptides Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Oral Proteins and Peptides Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Linaclotide
4.3.2 Plecanatide
4.3.3 Calcitonin
4.3.4 Insulin
4.3.5 Octreotide
5 Oral Proteins and Peptides Market: Product Analysis
-
5.1 Oral Proteins and Peptides Product Market Share Analysis, 2018 & 2026
-
5.2 Oral Proteins and Peptides Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Oral Proteins and Peptides Market: Application Analysis
-
6.1 Oral Proteins and Peptides Application Market Share Analysis, 2018 & 2026
-
6.2 Oral Proteins and Peptides Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Gastric & Digestive Disorders
6.3.2 Bone Diseases
6.3.3 Diabetes
6.3.4 Hormonal Disorders
7 Oral Proteins and Peptides Market: Regional Analysis
-
7.1 Oral Proteins and Peptides Regional Market Share Analysis, 2018 & 2026
-
7.2 Oral Proteins and Peptides Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Generex Biotechnology
9.1.1 Generex Biotechnology Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Synthetic Biologics
9.2.1 Synthetic Biologics Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Synergy Pharmaceuticals
9.3.1 Synergy Pharmaceuticals Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Biocon
9.4.1 Biocon Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Sanofi
9.5.1 Sanofi Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Novo Nordisk
9.6.1 Novo Nordisk Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Novartis
9.7.1 Novartis Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Allergan
9.8.1 Allergan Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Hoffmann-La Roche
9.9.1 Hoffmann-La Roche Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 AstraZeneca
9.10.1 AstraZeneca Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Tarsa Therapeutics
9.11.1 Tarsa Therapeutics Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Hovione
9.12.1 Hovione Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
The List of Tables and Figures (Totals 86 Figures and 132 Tables)
Figure Linaclotide Oral Proteins and Peptides market, 2015 - 2026 (USD Million)
Figure Plecanatide Oral Proteins and Peptides market, 2015 - 2026 (USD Million)
Figure Calcitonin Oral Proteins and Peptides market, 2015 - 2026 (USD Million)
Figure Insulin Oral Proteins and Peptides market, 2015 - 2026 (USD Million)
Figure Octreotide Oral Proteins and Peptides market, 2015 - 2026 (USD Million)
Figure Gastric & Digestive Disorders market, 2015 - 2026 (USD Million)
Figure Bone Diseases market, 2015 - 2026 (USD Million)
Figure Diabetes market, 2015 - 2026 (USD Million)
Figure Hormonal Disorders market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Oral Proteins and Peptides market, by country, 2015 - 2026 (USD Million)
-
Table North America Oral Proteins and Peptides market, by type, 2015 - 2026 (USD Million)
-
Table North America Oral Proteins and Peptides market, by product, 2015 - 2026 (USD Million)
-
Table North America Oral Proteins and Peptides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Oral Proteins and Peptides market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Oral Proteins and Peptides market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Oral Proteins and Peptides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Oral Proteins and Peptides market, by type, 2015 - 2026 (USD Million)
-
Table Canada Oral Proteins and Peptides market, by product, 2015 - 2026 (USD Million)
-
Table Canada Oral Proteins and Peptides market, by application, 2015 - 2026 (USD Million)
-
Table Europe Oral Proteins and Peptides market, by country, 2015 - 2026 (USD Million)
-
Table Europe Oral Proteins and Peptides market, by type, 2015 - 2026 (USD Million)
-
Table Europe Oral Proteins and Peptides market, by product, 2015 - 2026 (USD Million)
-
Table Europe Oral Proteins and Peptides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Oral Proteins and Peptides market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Oral Proteins and Peptides market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Oral Proteins and Peptides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Oral Proteins and Peptides market, by type, 2015 - 2026 (USD Million)
-
Table Germany Oral Proteins and Peptides market, by product, 2015 - 2026 (USD Million)
-
Table Germany Oral Proteins and Peptides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Oral Proteins and Peptides market, by type, 2015 - 2026 (USD Million)
-
Table France Oral Proteins and Peptides market, by product, 2015 - 2026 (USD Million)
-
Table France Oral Proteins and Peptides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Oral Proteins and Peptides market, by type, 2015 - 2026 (USD Million)
-
Table Italy Oral Proteins and Peptides market, by product, 2015 - 2026 (USD Million)
-
Table Italy Oral Proteins and Peptides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Oral Proteins and Peptides market, by type, 2015 - 2026 (USD Million)
-
Table Spain Oral Proteins and Peptides market, by product, 2015 - 2026 (USD Million)
-
Table Spain Oral Proteins and Peptides market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Oral Proteins and Peptides market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Oral Proteins and Peptides market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Oral Proteins and Peptides market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Oral Proteins and Peptides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Oral Proteins and Peptides market, by type, 2015 - 2026 (USD Million)
-
Table China Oral Proteins and Peptides market, by product, 2015 - 2026 (USD Million)
-
Table China Oral Proteins and Peptides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Oral Proteins and Peptides market, by type, 2015 - 2026 (USD Million)
-
Table Japan Oral Proteins and Peptides market, by product, 2015 - 2026 (USD Million)
-
Table Japan Oral Proteins and Peptides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Oral Proteins and Peptides market, by type, 2015 - 2026 (USD Million)
-
Table India Oral Proteins and Peptides market, by product, 2015 - 2026 (USD Million)
-
Table India Oral Proteins and Peptides market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Oral Proteins and Peptides market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Oral Proteins and Peptides market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Oral Proteins and Peptides market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Oral Proteins and Peptides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Oral Proteins and Peptides market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Oral Proteins and Peptides market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Oral Proteins and Peptides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Oral Proteins and Peptides market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Oral Proteins and Peptides market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Oral Proteins and Peptides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Oral Proteins and Peptides market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Oral Proteins and Peptides market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Oral Proteins and Peptides market, by application, 2015 - 2026 (USD Million)
-
Table MEA Oral Proteins and Peptides market, by country, 2015 - 2026 (USD Million)
-
Table MEA Oral Proteins and Peptides market, by type, 2015 - 2026 (USD Million)
-
Table MEA Oral Proteins and Peptides market, by product, 2015 - 2026 (USD Million)
-
Table MEA Oral Proteins and Peptides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Oral Proteins and Peptides market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Oral Proteins and Peptides market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Oral Proteins and Peptides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Oral Proteins and Peptides market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Oral Proteins and Peptides market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Oral Proteins and Peptides market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Generex Biotechnology Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Synthetic Biologics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Synergy Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Biocon Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novo Nordisk Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Allergan Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Hoffmann-La Roche Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Tarsa Therapeutics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Hovione Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
